Title:
【発明の名称】TH2介在性および関連疾患治療のための免疫応答修飾化合物
Document Type and Number:
Japanese Patent JP2001502699
Kind Code:
A
Abstract:
Immune response modifier compounds-imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, and 1,2-bridged imidazoquinoline amines-are useful for the treatment of TH2 mediated diseases by administering a therapeutically effective amount of such compounds in order to inhibit TH2 immune response, suppress IL-4/IL-5 cytokine induction and eosinophilia, as well as enhance TH1 immune response.
More Like This:
Inventors:
Tomai, Mark A.
Hammerbeck, David M.
Swingle, Karl F.
Hammerbeck, David M.
Swingle, Karl F.
Application Number:
JP51975298A
Publication Date:
February 27, 2001
Filing Date:
October 24, 1997
Export Citation:
Assignee:
Minnesota Mining and Manufacturing Company
International Classes:
A61K31/437; A61K31/47; A61K31/4745; A61K31/4748; A61P11/06; A61P31/00; A61P37/02; A61P37/08; C07D471/14; C07D471/04; C07D471/16; (IPC1-7): A61K31/437; A61K31/4745; A61P11/06; A61P31/00; A61P37/02; A61P37/08; C07D471/04; C07D471/14; C07D471/16
Attorney, Agent or Firm:
Takashi Ishida (4 others)